GSK, FDA warn doctors against dissolving Relenza

10/11/2009 | MarketWatch

The FDA and GlaxoSmithKline warned doctors that antiviral drug Relenza should not be administered with a nebulizer or ventilator, or "reconstituted in any liquid formulation." Relenza, which is sometimes dissolved for patients who cannot take oral medications, reportedly caused the death of an influenza patient who received the drug through a mechanical ventilator.

View Full Article in:

MarketWatch

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC